GB9828840D0 - Prostate cancer associated genes and their products - Google Patents

Prostate cancer associated genes and their products

Info

Publication number
GB9828840D0
GB9828840D0 GBGB9828840.0A GB9828840A GB9828840D0 GB 9828840 D0 GB9828840 D0 GB 9828840D0 GB 9828840 A GB9828840 A GB 9828840A GB 9828840 D0 GB9828840 D0 GB 9828840D0
Authority
GB
United Kingdom
Prior art keywords
products
prostate cancer
cancer associated
associated genes
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9828840.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nottingham Trent University
Original Assignee
Nottingham Trent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nottingham Trent University filed Critical Nottingham Trent University
Priority to GBGB9828840.0A priority Critical patent/GB9828840D0/en
Publication of GB9828840D0 publication Critical patent/GB9828840D0/en
Priority to PCT/GB1999/004359 priority patent/WO2000040752A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GBGB9828840.0A 1998-12-30 1998-12-30 Prostate cancer associated genes and their products Ceased GB9828840D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB9828840.0A GB9828840D0 (en) 1998-12-30 1998-12-30 Prostate cancer associated genes and their products
PCT/GB1999/004359 WO2000040752A2 (en) 1998-12-30 1999-12-22 Cancer associated genes and their products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828840.0A GB9828840D0 (en) 1998-12-30 1998-12-30 Prostate cancer associated genes and their products

Publications (1)

Publication Number Publication Date
GB9828840D0 true GB9828840D0 (en) 1999-02-17

Family

ID=10845169

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9828840.0A Ceased GB9828840D0 (en) 1998-12-30 1998-12-30 Prostate cancer associated genes and their products

Country Status (2)

Country Link
GB (1) GB9828840D0 (en)
WO (1) WO2000040752A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573095B1 (en) 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
AU2001245693A1 (en) * 2000-03-16 2001-10-03 Northwest Biotherapeutics, Inc. Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
WO2001090357A1 (en) * 2000-05-24 2001-11-29 Genesis Research & Development Corporation Limited Compositions isolated from skin cells and methods for their use
US20040072265A1 (en) * 2001-01-09 2004-04-15 Masahiro Toda Human glioma antigen and process for preparing the same
US7414032B2 (en) 2001-06-25 2008-08-19 Immunofrontier, Inc. Vaccine comprising a polynucleotide encoding an antigen recognized by a CD4+ helper T-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a CD8+ CTL
GB0218468D0 (en) * 2002-08-08 2002-09-18 Univ Nottingham Trent Gastric and Colon Cancer-associated antigens
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
EP2172477A1 (en) * 2008-10-06 2010-04-07 Atlas Antibodies AB Epitopes derived from SATB2 and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE342356T1 (en) * 1992-11-05 2006-11-15 Sloan Kettering Inst Cancer PROSTATE-SPECIFIC MEMBRANE ANTIGEN
US5925362A (en) * 1993-08-11 1999-07-20 Jenner Technologies Method to elicit an antitumor response with human prostate-specific antigen
CO4600637A1 (en) * 1996-03-15 1998-05-08 Corixa Corp COMPOUNDS FOR IMMUNOTHERAPY AND IMMUNODIAGNOSIS OF CANCER OF PROSTATE
AU6764398A (en) * 1997-03-20 1998-10-12 Variagenics, Inc. Target genes for allele-specific drugs
EP0996857B1 (en) * 1997-07-17 2009-09-09 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2000040752A3 (en) 2000-11-23
WO2000040752A2 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
AU3619400A (en) Human prostate cancer associated gene sequences and polypeptides
ZA200108258B (en) Methods of inducing cancer cell death and tumor regression.
EP0926955A4 (en) Conjugates useful in the treatment of prostate cancer
HUP0000651A3 (en) Conjugates useful in the treatment of prostate cancer
AU4823599A (en) Prostate cancer-associated genes
EP1012279A4 (en) Mitofusin genes and their uses
EP0972830A4 (en) Cancer-associated genes
IL136167A0 (en) Conjugates useful in the treatment of prostate cancer
GB9828840D0 (en) Prostate cancer associated genes and their products
GB9805877D0 (en) Cancer
EP1100808A4 (en) Prostate derived ets factor
GB0000993D0 (en) Cancer associated genes and their products
AU2238499A (en) Androgen-metabolic gene mutations and prostate cancer risk
IL136005A0 (en) Essential bacterial genes and their use
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
GB9703633D0 (en) Cancer therapy
AU4860299A (en) (zap-3) tumor associated genes and their uses
AU5416700A (en) Differentially expressed genes in prostate cancer
GB9613629D0 (en) Reg gene expression in cancer tissue
AU5316099A (en) Prostate cancer assays and related methods
AU3001899A (en) (zap-1) tumor associated genes and their uses
EP0871709A4 (en) Androgen-repressed metastatic human prostate cancer cell line
EP1133516A4 (en) Chromosome 17p-linked prostate cancer susceptibility gene
GB9903035D0 (en) Treating cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)